登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：301103 证券简称：何氏眼科 公告编号：2025-053 辽宁何氏眼科医院集团股份有限公司关于股东回馈活动的自愿性信息披露公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 辽宁何氏眼科医院集团股份有限公司（以下简称"公司"）成立三十周年之际，为建立长效、多样的股东 回报机制，感谢广大股东长期以来对公司的关注和支持，为感谢投资者的长期信任，进一步形成传播眼 健康、全民眼健康的良好氛围，公司开展"投资者健康回馈活动"，现将本次活动内容公告如下： 一、活动内容 1、医院为每位参与活动的股东配备专属眼健康服务顾问，提供 "全流程便捷服务"； 2、视光产品类优惠：角膜塑形镜、近视管理镜片、框架眼镜等； 3、诊疗项目专属优惠：眼脑视觉训练、基因检测项目、睑板腺按摩治疗等； 4、近视矫正屈光手术股东专属优惠； 5、医美项目； 6、眼健康检查专属方案。 二、参加活动的股东范围 包括现有股东、历史股东及未来投资者，股东本人及直系亲属（配偶、父母、子女）。 五、参与方式 ■ 更多活动细节，通过微信搜索 "何氏眼科 ...

记者提问：生活中，不少人遇到过疼痛的困扰。有的人一头痛、关节痛就吃止痛药。而有的人认为"头痛扛一扛就过去"，也有人认为"经常吃止痛药会上 瘾"，请问这种说法对吗？ 李 水 清 D 冬至节气的到来，标志着各地气候进入最寒冷的阶段。目前，仍处于流感等呼吸道疾病的高发期，国家卫建委提醒公众继续保持科学佩戴口罩、勤洗手、常 通风等良好卫生习惯，积极接种流感疫苗，做好个人防护，平安健康过冬。 今天下午，国家卫建委召开新闻发布会， 围绕冬至时节养生保健、流感防控和疫苗接种、呼吸系统疾病防治、常见疼痛防治、眼健康等主题，请相关方面 专家回答大家的提问。 ...

记者提问：一些老年人认为疼痛是"老了的自然现象"而不去治疗，这种认知是否正确？老年人中带状疱疹高发，并且容易出现带状疱疹后神经痛，针对这个 有哪些预防和治疗的好方法？ 李 水 清 D 冬至节气的到来，标志着各地气候进入最寒冷的阶段。目前，仍处于流感等呼吸道疾病的高发期，国家卫健委提醒公众继续保持科学佩戴口罩、勤洗手、常 通风等良好卫生习惯，积极接种流感疫苗，做好个人防护，平安健康过冬。 今天下午，国家卫建委召开新闻发布会， 围绕冬至时节养生保健、流感防控和疫苗接种、呼吸系统疾病防治、常见疼痛防治、眼健康等主题，请相关方面 专家回答大家的提问。 ...

Core Viewpoint - The "2025 International Genomics Conference on Ophthalmology (ICG EYE) and CGT Innovation and Industrial Transformation Summit" highlighted the integration of cell and gene therapy (CGT) in eye health and anti-aging applications, showcasing new ideas, trends, technologies, and results [1] Group 1: Event Overview - The conference featured a forum themed "CGT + Anti-Aging Mechanisms and Applications," where experts and industry leaders engaged in discussions on practical applications of CGT in eye health and anti-aging [1] - The event served as a platform for international exchange, fostering innovation in the integration of CGT technology with eye health and anti-aging fields [1] Group 2: Company Initiatives - Liaoning He’s Eye Hospital Group Co., Ltd. (301103) collaborated with various institutions to form a synergistic innovation matrix, focusing on precision medicine [1] - The company established the first eye gene bank and clinical application research center for ophthalmic stem cells in China, targeting eye health, anti-aging, and longevity technology [1] Group 3: Research Focus - The company is concentrating on three core areas: gene therapy, stem cell regenerative medicine, and intelligent ophthalmic equipment data applications [1] - The aim is to conduct cutting-edge technology research to address complex eye disease issues and promote the deep integration of technology with healthcare data [1] Group 4: Market Expansion - The company is actively expanding into overseas markets to promote the globalization and accessibility of regenerative medical technologies [1] - The successful forum is expected to inject innovative momentum into the high-quality development of eye health and longevity industries as related technologies accelerate and the ecosystem improves [1]

Core Viewpoint - The establishment of the Tai'an Maternal and Child Health Hospital's Ophthalmology and Eye Health Professional Committee is a significant step towards improving eye health services, particularly for children and adolescents, in response to changing demographics and increasing eye health issues [1][2]. Group 1: Committee Formation and Leadership - The committee was officially formed during a conference held on October 18, 2025, with key leaders elected, including Pan Yingfen as the chairperson and ten vice-chairpersons [1]. - The committee aims to be a leader in standardized diagnosis and treatment, promote technological innovation, and safeguard public eye health [1][2]. Group 2: Focus Areas and Future Directions - The committee will focus on three main areas: academic enhancement, service network construction, and health education, with a particular emphasis on preventing myopia in children and adolescents [2]. - The goal is to improve the eye health service system throughout the life cycle and ensure the well-being of citizens, especially children [2]. Group 3: Academic Exchange and Collaboration - Following the establishment meeting, a high-level academic exchange was held, featuring lectures from prominent experts on various topics related to eye health, including treatment for high myopia and pediatric cataracts [2]. - The committee's formation is expected to enhance the standardization of eye care services in the city, strengthen academic exchanges, and foster technical cooperation [2].

Core Insights - Climate change is leading to unprecedented increases in global surface temperatures, with 2024 projected to be 1.49°C higher than pre-industrial levels, marking a continuous trend of record-breaking heat [1] - The health impacts of climate change are significant, with the WHO estimating that by 2030, climate-related hazards could result in approximately 250,000 deaths annually and health costs ranging from $2 billion to $4 billion [2][3] - Climate change is linked to various health issues, including heat-related illnesses, food poisoning, and the exacerbation of respiratory and cardiovascular diseases [3][4] Impact on Eye Health - Research indicates that climate change adversely affects eye health, with rising temperatures correlating with increased cases of cataracts and other eye diseases [7][8] - A study in Spain found that for every 1°C increase in average annual temperature, there is an increase of 371 cataract cases per 100,000 residents [7] - In China, populations experiencing extreme temperatures show significantly higher rates of glaucoma and conjunctivitis [8] Mechanisms of Impact - High temperatures can lead to heat stress, which damages the eye's natural defenses and contributes to cataract formation [10][12] - Increased UV radiation due to ozone depletion can cause direct damage to eye tissues, leading to conditions such as corneal inflammation and cataracts [12] - Air pollution, including particulate matter, negatively impacts tear film quality and can lead to dry eye symptoms and other ocular diseases [13][14] Vulnerable Populations - Certain groups are more susceptible to the eye health impacts of climate change, including children, pregnant women, the elderly, individuals with pre-existing health conditions, and outdoor workers [18][19][20][21][22] - Children are particularly at risk due to their increased exposure to UV radiation and lack of protective awareness [18] - Pregnant women may experience changes in eye health due to physiological changes during pregnancy [19] Protective Measures - Recommendations for protecting eye health include wearing UV-protective sunglasses, maintaining indoor humidity, reducing screen time, and ensuring a balanced diet rich in essential nutrients [23][24][25][26] - Regular eye examinations are advised, especially for those over 50 or with pre-existing conditions [28]

Group 1 - Raytheon Technology announced a joint investment with Jiangsu Huiding Optical Glasses Co., Ltd. and Optecon Vision Investment Co., Ltd. to establish Jiangsu Rayou Huiding Smart Glasses Co., Ltd., with Raytheon holding a 35% stake [1] - The establishment of the joint venture is expected to enhance the market expansion and strategic layout of Raytheon's smart glasses business [1] Group 2 - Raytheon Technology is recognized as the "first stock in e-sports equipment" on the Beijing Stock Exchange and has been listed in the "China's 500 Most Valuable Brands" for five consecutive years, with a brand value of 21.839 billion [3] - The Raytheon AI Magic Mirror (Raytheon Aura AI Smart Shooting Glasses) was officially launched on June 17, featuring a 1.2 million pixel camera, Sony IMX681 sensor, and Qualcomm Snapdragon AR1 chip, weighing only 39g [3] - Huiding Optical is one of the top three optical brands in China by lens sales, with a service network covering over 2,100 clients nationwide [3] - Optecon Vision is the first listed high-tech enterprise in the eye care sector in China, collaborating with over 1,500 well-known medical institutions and covering more than 2,000 professional optical channel partners [3] Group 3 - The partnership aims to leverage Huiding Optical and Optecon Vision's nationwide sales channels and user resources to accelerate the penetration of Raytheon AI Magic Mirror into offline channels [4] - The collaboration will also provide professional support for the development and upgrade of Raytheon's smart glasses through their teams specializing in myopia prevention and eye health management [4] - This initiative is part of Raytheon Technology's strategy to create a closed-loop ecosystem encompassing product development, channel access, and terminal services [4] Group 4 - According to the National Health Commission, the number of myopia patients in China has exceeded 700 million, with offline optical stores being the primary sales channel for glasses [6] - Euromonitor International indicates that offline optical stores will account for 81.8% of the eyewear sales channels in China by 2024, making them a crucial channel for promoting AI/AR glasses [6] - Raytheon Technology aims to transform into a diversified multi-channel layout, seizing the initiative in the industry chain layout [6] - The company is committed to providing an exceptional user experience and plans to collaborate with more ecosystem partners in product development, market expansion, and service ecosystem construction [6]

Core Insights - The eye health industry in China is evolving from a single treatment model to a comprehensive lifecycle health management approach, creating diverse market demands and consumption scenarios [1] - Santen Pharmaceutical is increasing its resource investment in China to explore business models that align with its product attributes, aiming to develop a "second curve" for growth in the Chinese market [1] Company Strategy - Santen's "China 2.0 Strategy" focuses on embracing consumer needs beyond serious medical treatments, recognizing the diversification of healthcare supply and demand in China [2] - The strategic upgrade is encapsulated in the 'R-E-A-C-H' model, which includes Retail, E-commerce, Ahead (Bay Area project), CSO (Contract Sales Organization), and Hospital channels to enhance market penetration and business development [2] Investment and Production Capacity - Santen is investing in deep value chain integration, with a new production base in Suzhou set to have an annual capacity exceeding 800 million eye drops, enhancing supply capabilities in the Asia-Pacific region [3] - The company is committed to long-term investment in China, with its own R&D center and a top-tier professional team, aiming to leverage China's strong production capacity and innovative environment [3] Market Potential - The eye health market in China is viewed as a blue ocean with untapped potential, and Santen calls for collaboration across the industry to build a local eye care ecosystem [4] - The value of the Chinese ophthalmology market lies not only in its size but also in the potential for ecological collaboration to unlock unexploited opportunities [4]

Group 1 - The China Medical Device Industry Association Ophthalmic Device Professional Committee held a meeting from May 23 to 28, 2025, where a new chairman was elected, with Chen Biao from Johnson & Johnson Vision Care China appointed as the new chairman [1] - China has the highest number of blind and visually impaired individuals in the world, with increasing rates of myopia among children and adolescents, and a growing incidence of eye diseases in the elderly population [1] - The aging population, changing eye usage patterns, and rising public health demands pose ongoing challenges for comprehensive eye disease prevention and treatment throughout the life cycle [1] Group 2 - Chen Biao expressed gratitude for the trust and support received, emphasizing the committee's commitment to enhancing innovation, industry standards, and serving national strategic needs in the critical period of the "14th Five-Year Plan" for eye health [2] - Johnson & Johnson has been dedicated to developing transformative innovative products to improve eye health, focusing on technological innovation and breakthroughs in the eye health sector in China [2] - The company aims to accelerate the introduction of cutting-edge ophthalmic technologies and innovative products in China, enhancing the safety and outcomes of eye surgeries for domestic patients [2]

Group 1 - The "2025 National Vision Health Popularization Action" was officially launched in Beijing, focusing on building an eye health ecosystem through multi-party collaboration [1] - Dr. Luo Yan from Peking Union Medical College Hospital emphasized the importance of comprehensive pre-operative assessments and scientific post-operative care for adult myopia correction surgeries [1][3] - The two main types of adult myopia correction surgeries are corneal laser surgery and intraocular lens surgery, with the latter offering a wider correction range and higher safety [3] Group 2 - For patients with high myopia, post-operative eye care is crucial to prevent further deterioration and retinal diseases, with recommendations for regular eye examinations every 3-5 years [3] - Patients with dry eye syndrome should select surgical methods based on the severity of their condition, with mild cases being less impactful on surgery outcomes [3] - Dr. Luo highlighted that patients with moderate to severe dry eye may benefit more from intraocular lens implantation, which has less impact on the cornea and faster vision recovery [3]